Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The Journal of Investigative Dermatology|September 24, 2018
Research Techniques Made Simple: CAR T-Cell TherapyHaziq F Siddiqi, Karl W Staser, Vinod E NambudiriJournal of Cutaneous Pathology|June 26, 2021
Histopathologic and immunophenotypic features of cutaneous solid organ transplant-associated graft-vs-host disease: Comparison with acute hematopoietic cell transplant-associated graft-vs-host disease and cutaneous drug eruptionAaron J Russell, Amy C Musiek, Karl W Staser, et al.Journal of the American Academy of Dermatology|June 25, 2019
Histopathologic upgrading of nonmelanoma skin cancer at the time of Mohs micrographic surgery: A prospective reviewRachel L Kyllo, Karl W Staser, Ilana Rosman, et al.Preventing Chronic Disease|April 12, 2011
Dietary behaviors associated with fruit and vegetable consumption, Marion County, Indiana, 2005Karl W Staser, Terrell W Zollinger, Robert M Saywell, et al.Journal of the American Academy of Dermatology|June 15, 2025
RASopathies. Part I: Genetics and therapeutic considerationsZachary J Jaeger, Natalia Maverakis Ramirez, Ashley D Osborne, et al.Journal of the American Academy of Dermatology|June 18, 2025
RASopathies. Part II: Cutaneous and extracutaneous manifestationsZachary J Jaeger, Natalia K A Maverakis Ramirez, Ashley D Osborne, et al.Nature Communications|June 13, 2022
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activityMiriam Y Kim, Reyka Jayasinghe, Jessica M Devenport, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 29, 2015
Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal HomeostasisSteven D Rhodes, Hao Yang, Ruizhi Dong, et al.Leukemia|October 5, 2023
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignanciesJingyu Xiang, Jessica M Devenport, Alun J Carter, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 25, 2013
Hyperactive transforming growth factor-β1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse modelSteven D Rhodes, Xiaohua Wu, Yongzheng He, et al.Pageof 2